These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 750110)
1. Relationship of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) pharmacokinetics of uptake, distribution, and tissue/plasma partitioning in rat organs and intracerebral tumors. Levin VA; Kabra PA; Freeman-Dove MA Cancer Chemother Pharmacol; 1978; 1(4):233-42. PubMed ID: 750110 [TBL] [Abstract][Full Text] [Related]
2. The effect of phenobarbital pretreatment on the antitumor activity of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl-1-nitrosourea (PCNU), and on the plasma pharmacokinetics and biotransformation of BCNU. Levin VA; Stearns J; Byrd A; Finn A; Weinkam RJ J Pharmacol Exp Ther; 1979 Jan; 208(1):1-6. PubMed ID: 759602 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of nitrosoureas: comparison of 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) after oral and intravenous administration to rats. Russo RG; Cattaneo MT; Bartosek I Tumori; 1984 Dec; 70(6):499-502. PubMed ID: 6531792 [TBL] [Abstract][Full Text] [Related]
4. Chemosensitization of the nitrosoureas by 2-nitroimidazoles in the subcutaneous 9L tumor model: pharmacokinetic and structure-activity considerations. Wong KH; Wallen CA; Wheeler KT Int J Radiat Oncol Biol Phys; 1990 May; 18(5):1043-50. PubMed ID: 2140824 [TBL] [Abstract][Full Text] [Related]
5. Mechanism of uptake of nitrosoureas by L5178Y lymphoblasts in vitro. Begleiter A; Lam HP; Goldenberg GJ Cancer Res; 1977 Apr; 37(4):1022-7. PubMed ID: 557367 [TBL] [Abstract][Full Text] [Related]
6. Distribution of Bratton-Marshall-positive material in mice following intravenous injections of nitrosoureas. Kari P; McConnell WR; Finkel JM; Hill DL Cancer Chemother Pharmacol; 1980; 4(4):243-8. PubMed ID: 7438326 [TBL] [Abstract][Full Text] [Related]
7. Metabolism of 1,3-bis(2-chloroethyl)-1-nitrosourea by rat hepatic microsomes. Lin HS; Weinkam RJ J Med Chem; 1981 Jun; 24(6):761-3. PubMed ID: 7252986 [TBL] [Abstract][Full Text] [Related]
8. Induction of specific-locus and dominant lethal mutations in male mice by 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU). Ehling UH; Adler ID; Favor J; Neuhäuser-Klaus A Mutat Res; 1997 Oct; 379(2):219-31. PubMed ID: 9357551 [TBL] [Abstract][Full Text] [Related]
9. Binding of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea to L1210 cell nuclear proteins. Woolley PV; Dion RL; Kohn KW; Bono VH Cancer Res; 1976 Apr; 36(4):1470-4. PubMed ID: 4221 [TBL] [Abstract][Full Text] [Related]
10. Capillary gas chromatography and thermionic N-P-specific detection of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) or 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in stability and pharmacokinetic studies. El-Yazigi A; Martin CR Pharm Res; 1988 Apr; 5(4):220-5. PubMed ID: 3247301 [TBL] [Abstract][Full Text] [Related]
11. In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines. Mulcahy RT; Siemann DW Cancer Res; 1983 Oct; 43(10):4709-13. PubMed ID: 6883329 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of RNA synthesis in murine ependymoblastoma by the combination of amphotericin B and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea. Laurent G; Dewerie-Vanhouche J; Machin D; Hildebrand J Cancer Res; 1980 Mar; 40(3):939-42. PubMed ID: 7471107 [TBL] [Abstract][Full Text] [Related]
13. Mechanism of action of the nitrosoureas--IV. Reactions of bis-chloroethyl nitrosourea and chloroethyl cyclohexyl nitrosourea with deoxyribonucleic acid. Gombar CT; Tong WP; Ludlum DB Biochem Pharmacol; 1980 Oct; 29(19):2639-43. PubMed ID: 7191706 [No Abstract] [Full Text] [Related]
14. Lysis of human promyelocytic HL-60 cells by amphotericin B in combination with 2-chloroethyl-1-nitrosoureas: role of the carbamoylating activity of nitrosoureas. Brajtburg J; Elberg S; Schechtman KB; Medoff G Cancer Res; 1990 Jun; 50(11):3274-8. PubMed ID: 2334920 [TBL] [Abstract][Full Text] [Related]
15. Stereoselective monooxygenation of carcinostatic 1-(2-chloroethyl)-3-(cyclohexyl)-1-nitrosourea and 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea by purified cytochrome P-450 isozymes. Potter DW; Levin W; Ryan DE; Thomas PE; Reed DJ Biochem Pharmacol; 1984 Feb; 33(4):609-13. PubMed ID: 6704177 [TBL] [Abstract][Full Text] [Related]
16. The binding of 14C labelled 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) to macromolecules of sensitive and resistant tumours. Connors TA; Hare JR Br J Cancer; 1974 Nov; 30(5):477-80. PubMed ID: 4469198 [No Abstract] [Full Text] [Related]
17. Differential distribution and covalent binding of two labeled forms of methyl-CCNU in the Fischer 344 rat. Kramer RA; McMenamin MG; Boyd MR Cancer Chemother Pharmacol; 1985; 14(2):150-5. PubMed ID: 3971479 [TBL] [Abstract][Full Text] [Related]
18. Modification of CCNU pharmacokinetics by misonidazole--a major mechanism of chemosensitization in mice. Lee FY; Workman P Br J Cancer; 1983 May; 47(5):659-69. PubMed ID: 6849803 [TBL] [Abstract][Full Text] [Related]
19. Lipid association improves the therapeutic index of lomustine [1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea] to suppress 36B-10 tumor growth in rats. Bethune CR; Geyer RJ; Spence AM; Ho RJ Cancer Res; 2001 May; 61(9):3669-74. PubMed ID: 11325837 [TBL] [Abstract][Full Text] [Related]
20. The effects of BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea) and CCNU (1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea) on glutathione reductase and other enzymes in mouse tissue. Maker HS; Weiss C; Brannan TS Res Commun Chem Pathol Pharmacol; 1983 Jun; 40(3):355-66. PubMed ID: 6622814 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]